ArticleNPJ precision oncology2025

Quantitative ultrasound imaging for predicting response and guiding personalized neoadjuvant chemotherapy in breast cancer: randomized phase 2 clinical trial results.

Daniel Moore-Palhares et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.